The significant and growing global prevalence of diabetes continues to challenge people
with diabetes (PwD), healthcare providers, and payers. While maintaining near-normal …

The American Diabetes Association (ADA)“Standards of Care in Diabetes” includes the
ADA's current clinical practice recommendations and is intended to provide the components …

Background Open-source automated insulin delivery (AID) systems are used by many
patients with type 1 diabetes. Data are needed on the efficacy and safety of an open-source …

Aim Automated insulin delivery systems have improved glycaemic control in people with
type 1 diabetes mellitus. The analysis investigated predictors of improved sensor glucose …

Diabetes technologies represent a paradigm shift in type 1 diabetes care. Continuous
subcutaneous insulin infusion (CSII) pumps and continuous glucose monitors (CGM) …

The 2023 Diabetes Clinical Practice Guidelines, developed by the Korean Diabetes
Association (KDA), aim to provide evidence-based recommendations for the diagnosis …

There is a need to optimize closed-loop automated insulin delivery in type 1 diabetes. We
assessed the glycemic efficacy and safety of empagliflozin 25 mg d− 1 as add-on therapy to …

The American Diabetes Association (ADA)“Standards of Care in Diabetes” includes the
ADA's current clinical practice recommendations and is intended to provide the components …

OBJECTIVE We evaluated the safety and efficacy of fully closed-loop with ultrarapid insulin
lispro in adults with type 1 diabetes and suboptimal glycemic control compared with insulin …

Background: The Omnipod® 5 Automated Insulin Delivery System was associated with
favorable glycemic outcomes for people with type 1 diabetes (T1D) in two pivotal clinical …